Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

4.93
Delayed Data
As of 3:46pm ET
 +0.0699 / +1.44%
Today’s Change
3.05
Today|||52-Week Range
10.90
-6.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
AssetsCash15.9M18.0M16.5M12.7M
 
 
 
 
 
Short Term Investment Cash-1.2M2.1M-1.5M-3.8M
 
 
 
 
 
Cash & Short Term Investments15.9M18.0M16.5M12.7M
 
 
 
 
 
 
ReceivablesReceivables1.5M3.5M2.1M3.3M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses1.1M845.0K867.0K705.0K
 
 
 
 
 
Other Current Assets227.0K161.0K173.0K269.0K
 
 
 
 
 
Current Assets18.8M22.6M19.6M17.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----6.4M--
 
 
Depreciation-----6.3M--
 
 
Other Assets0.000.000.000.00--
Total Assets18.9M22.7M19.7M17.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.9M2.0M2.5M1.7M
 
 
 
 
 
Accrued Expenses3.5M3.4M2.3M2.1M
 
 
 
 
 
Other Current Liabilities3.7M3.6M2.8M2.5M
 
 
 
 
 
Other Liabilities5.6M5.6M5.3M4.1M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities150.0K141.0K130.0K127.0K
 
 
 
 
 
Total Liabilities5.7M5.7M5.4M4.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity13.2M16.9M14.3M12.8M
 
 
 
 
 
Total Shareholder Equity13.2M16.9M14.3M12.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding3.0M4.3M4.3M4.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.